Cookies on VetMed Resource

Like most websites we use cookies. This is to ensure that we give you the best experience possible.

 

Continuing to use www.cabi.org  means you agree to our use of cookies. If you would like to, you can learn more about the cookies we use.

VetMed Resource

Veterinary information to support practice, based on evidence and continuing education

Sign up to receive our Veterinary & Animal Sciences e-newsletter, book alerts and offers direct to your inbox.

Results per page:

Search results

Abstract

Infections with feline immunodeficiency virus (FIV) are common in New Zealand, although the impact of those infections on the health status of the cats remains unclear. Although many cats are vaccinated yearly with a commercial FIV vaccine containing FIV subtypes A and D, the effectiveness of this...

Author(s)
Stickney, A.; Ghosh, S.; Cave, N. J.; Dunowska, M.
Publisher
Elsevier B.V., Amsterdam, Netherlands
Citation
Veterinary Microbiology, 2020, 250,
Abstract

With the commercial release in Australia in 2004 of a vaccine against feline immunodeficiency virus (FIV; Fel-O-Vax FIV®), the landscape for FIV diagnostics shifted substantially. Point-of-care (PoC) antibody detection kits, which had been the mainstay for diagnosing FIV infection since the early...

Author(s)
Westman, M. E.; Malik, R.; Norris, J. M.
Publisher
Wiley, Melbourne, Australia
Citation
Australian Veterinary Journal, 2019, 97, 3, pp 47-55
Abstract

We recently showed that two immunochromatography point-of-care FIV antibody test kits (Witness FeLV/FIV and Anigen Rapid FIV/FeLV) were able to correctly assign FIV infection status, irrespective of FIV vaccination history, using whole blood as the diagnostic specimen. A third FIV antibody test...

Author(s)
Westman, M. E.; Malik, R.; Hall, E.; Norris, J. M.
Publisher
Elsevier Ltd, Oxford, UK
Citation
Comparative Immunology, Microbiology & Infectious Diseases, 2016, 46, pp 66-72
Abstract

Objectives: Recently, two point-of-care (PoC) feline immunodeficiency virus (FIV) antibody test kits (Witness and Anigen Rapid) were reported as being able to differentiate FIV-vaccinated from FIV-infected cats at a single time point, irrespective of the gap between testing and last vaccination...

Author(s)
Westman, M. E.; Malik, R.; Hall, E.; Harris, M.; Hosie, M. J.; Norris, J. M.
Publisher
Sage Publications, Thousand Oaks, USA
Citation
Journal of Feline Medicine and Surgery, 2017, 19, 10, pp 1055-1064
Abstract

Feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) are among the most important feline infectious diseases worldwide. This retrospective study investigated survival times and effects of selected predictor factors on survival time in a population of owned pet cats in Northern Italy ...

Author(s)
Spada, E.; Perego, R.; Sgamma, E. A.; Proverbio, D.
Publisher
Elsevier B.V., Amsterdam, Netherlands
Citation
Preventive Veterinary Medicine, 2018, 150, pp 38-46
Abstract

Conflicting accounts have been published in the veterinary literature regarding transmission of feline immunodeficiency virus (FIV) between cohabiting cats in mixed households, and the mechanics of possible casual transmission, if it occurs, are poorly understood. Similarly, there are conflicting...

Author(s)
Litster, A. L.
Publisher
Elsevier Ltd, Oxford, UK
Citation
Veterinary Journal, 2014, 201, 2, pp 184-188
Abstract

Oral lesions are common problems in feline medicine worldwide, and may be associated with different causes, such as infectious agents. There are only a few studies reporting the chief oral diseases and the results for retrovirus tests in shelter cats in Brazil, especially in the South region. This...

Author(s)
Silva, A. P.; Flores, M.; Mazaro, R.; Luz, F.; Silva, M.; Fighera, R. A.
Publisher
Colégio Brasileiro de Patologia Animal, Rio de Janeiro, Brazil
Citation
Pesquisa Veterinária Brasileira, 2019, 39, 7, pp 516-522
Abstract

A case-control field study was undertaken to determine the level of protection conferred to client-owned cats in Australia against feline immunodeficiency virus (FIV) using a commercial vaccine. 440 cats with outdoor access from five Australian states/territories underwent testing, comprising 139...

Author(s)
Westman, M. E.; Malik, R.; Hall, E.; Harris, M.; Norris, J. M.
Publisher
Elsevier Ltd, Oxford, UK
Citation
Vaccine, 2016, 34, 39, pp 4752-4758
Abstract

Feline Immunodeficiency Virus (FIV) is the most prominent retrovirus in cats. Molecular studies on FIV are of great importance to enable further studies, for example, understanding the pathogenesis and developing improved vaccines. We aimed to elucidate the molecular status of FIV and provide a...

Author(s)
Koç, B. T.; Oguzoglu, T. Ç.
Publisher
Elsevier Ltd, Oxford, UK
Citation
Comparative Immunology, Microbiology & Infectious Diseases, 2020, 73,
Abstract

Antibody testing based on individual risk assessments is recommended to determine feline immunodeficiency virus (FIV) status, but ELISA and Western blot tests cannot distinguish between anti-FIV antibodies produced in response to natural infection and those produced in response to FIV vaccination....

Author(s)
Litster, A.; Lin, J. M.; Nichols, J.; Weng, H. Y.
Publisher
Elsevier B. V., Amsterdam, Netherlands
Citation
Veterinary Microbiology, 2014, 170, 3/4, pp 197-205

Refine Results

Sort Order
Author
Geographical Location
Item Type
Language
Organisms
Subject Topics

Datasheet Filter

Datasheet Type